OMNICELL, INC.OMCL财报
Nasdaq · 工业 · 电子计算机
Omnicell是总部位于美国加州山景城的跨国医疗科技企业，专注于为医院及各类医疗机构提供药品管理自动化系统，同时面向零售药房推出用药依从性包装与患者互动软件，旗下产品使用Omnicell及EnlivenHealth两大品牌。
营收
$269.7M
毛利润
$110.9M
营业利润
$-11.6M
净利润
$-7.0M
毛利率
41.1%
营业利润率
-4.3%
净利率
-2.6%
同比增长
9.6%
EPS
$-0.15
资金流向
OMNICELL, INC. Q1 2025 财务摘要
OMNICELL, INC. Q1 2025营收 $269.7M（同比增长 9.6%），净利润 $-7.0M（同比增长 55.2%）（净利率 -2.6%）。销售成本 $158.7M，运营费用 $122.6M。
核心财务指标
| 总营收 | $269.7M |
|---|---|
| 净利润 | $-7.0M |
| 毛利率 | 41.1% |
| 营业利润率 | -4.3% |
| 报告期 | Q1 2025 |
营收拆解
OMNICELL, INC. Q1 2025营收 $269.7M 共来自 4 个业务板块，最大板块 Connected Devices Software Licenses And Other 贡献 $120.1M（占 44.5%）。
| 业务分部 | 营收 | 占比 |
|---|---|---|
| Connected Devices Software Licenses And Other | $120.1M | 44.5% |
| Saa S And Expert Services | $63.1M | 23.4% |
| Technical Services | $61.4M | 22.8% |
| Consumables | $25.1M | 9.3% |
OMNICELL, INC. 分部营收 — 季度趋势
OMNICELL, INC. 过去 4 个季度各业务板块营收走势，展示 Connected Devices Software Licenses And Other and Saa S And Expert Services 等业务的变化。
| 业务分部 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Connected Devices Software Licenses And Other | $154.2M | $152.6M | $138.6M | $120.1M |
| Saa S And Expert Services | $66.5M | $65.9M | — | $63.1M |
| Technical Services | $67.6M | $67.3M | — | $61.4M |
| Consumables | $25.6M | $24.9M | $24.6M | $25.1M |
OMNICELL, INC. 年度营收
OMNICELL, INC. 历年营收汇总，含各年度总量（例如 2025 年营收为 $1.2B）。
| 年份 | 年营收 |
|---|---|
| 2025 | $1.2B |
| 2024 | $1.1B |
| 2023 | $1.1B |
| 2022 | $1.3B |
OMNICELL, INC. 季度营收与净利润历史
OMNICELL, INC. 最近 8 个季度的营收、净利润及同比增速
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $314.0M | +2.3% | N/A | N/A |
| Q3 2025 | $310.6M | +10.0% | $5.5M | 1.8% |
| Q2 2025 | $290.6M | +5.0% | $5.6M | 1.9% |
| Q1 2025 | $269.7M | +9.6% | $-7.0M | -2.6% |
| Q4 2024 | $306.9M | +18.6% | N/A | N/A |
| Q3 2024 | $282.4M | -5.4% | $8.6M | 3.1% |
| Q2 2024 | $276.8M | -7.4% | $3.7M | 1.3% |
| Q1 2024 | $246.2M | -15.3% | $-15.7M | -6.4% |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $246.2M | $276.8M | $282.4M | $306.9M | $269.7M | $290.6M | $310.6M | $314.0M |
| 同比增长 | -15.3% | -7.4% | -5.4% | 18.6% | 9.6% | 5.0% | 10.0% | 2.3% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $2.28B | $2.29B | $2.30B | $2.12B | $2.15B | $2.15B | $1.95B | $1.97B |
| 总负债 | $1.10B | $1.09B | $1.07B | $877.6M | $894.4M | $881.9M | $727.7M | $742.9M |
| 股东权益 | $1.19B | $1.20B | $1.23B | $1.24B | $1.26B | $1.26B | $1.22B | $1.23B |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $50.0M | $58.7M | $22.8M | $56.3M | $25.9M | $42.8M | $28.3M | $30.4M |